ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Latest Magazine Issues
Apr 2026
Jan 2026
Latest Journal Issues
Nuclear Science and Engineering
May 2026
Nuclear Technology
March 2026
Fusion Science and Technology
Latest News
Chernobyl at 40 years: Looking back at Nuclear News
Sunday, April 26, at 1:23 a.m. local time will mark 40 years since the most severe nuclear accident in history: the meltdown of Unit 4 at the Chernobyl nuclear power plant in Ukraine, then part of the Soviet Union.
In the ensuing four decades, countless books, documentaries, articles, and conference sessions have examined Chernobyl’s history and impact from various angles. There is a similar abundance of outlooks in the archives of Nuclear News, where hundreds of scientists, advocates, critics, and politicians have shared their thoughts on Chernobyl over the years. Today, we will take a look at some highlights from the pages of NN to see how the story of Chernobyl evolved over the decades.
Isao Murata, Shingo Tamaki, Sachie Kusaka, Indah Rosidah Maemunah, Fuminobu Sato, Hiroyuki Miyamaru, Shigeo Yoshida
Fusion Science and Technology | Volume 79 | Number 4 | May 2023 | Pages 465-475
Technical Paper | doi.org/10.1080/15361055.2022.2151280
Articles are hosted by Taylor and Francis Online.
A fusion reactor is known as a neutron-rich nuclear energy source. In this paper, neutrons are utilized to form an epithermal neutron irradiation field for boron neutron capture therapy (BNCT). Using the International Thermonuclear Experimental Reactor (ITER) facility, a beam shaping assembly (BSA) was designed and placed just before the biological shield. Treatments were planned to be carried out just outside the biological shield. An opening was prepared in the vacuum vessel to guide deuteron-triton neutrons to the BSA. The BSA is about 1 m in thickness, and on the outside surface of the BSA, an epithermal neutron flux of 1 × 109 n/s‧cm−2 was aimed. As a result of the design, the irradiation field successfully met the design criteria of the BSA advocated by the International Atomic Energy Agency. The BSA moderator consists of a first filter of 45-cm-thick iron and a second filter of 70-cm-radius and 40-cm-thick AlF3. The epithermal neutron beam was available for diameters from 10 to 20 cm to cope with various sizes of tumors. Also, a titanium layer was specially introduced to remove fast neutrons just above 10 keV to reduce the fast neutron contribution. In addition, a caldera-shaped collimator was set just outside of the BSA to form a broad beam and to make the current-to-flux ratio larger than 0.7. It was shown from the present design that the performance was confirmed to be excellent compared to other BNCT facilities available at present, meaning that even deep-seated cancer treatment could be realized in the future in ITER.